Package Leaflet: Information for the User
Desmopresina Aristo120 micrograms sublingual tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Desmopressin, the active substance of Desmopresina Aristo, acts like the natural pituitary hormone vasopressin and regulates the amount of urine produced by the body.
Desmopressin is used to treat
Do not take Desmopresina Aristo:
Warnings and precautions
Consult your doctor or pharmacist before starting to take desmopressin.
Treatment of enuresis (nocturnal involuntary urination) in children begins with lifestyle measures and a nocturnal enuresis alarm (a device that emits a sound or vibrates when wet). If these measures fail or pharmacological treatment is necessary, treatment with desmopressin may be initiated.
Consult your doctor before using desmopressin
When using this medicine for enuresis or nocturia, reduce fluid intake to a minimum 1 hour before taking a tablet until 8 hours after taking this medicine.
Desmopressin should be used with caution in patients with fluid imbalance. Consult your doctor if, in relation to an acute illness, you have altered fluid and/or electrolyte balance.
Children
In children, the use of this medicine should be done under adult supervision.
Do not administer this medicine to children under 5 years of age.
Other medicines and Desmopresina Aristo
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
The effect of desmopressin may be increased, with a greater risk of fluid retention, if taken at the same time as certain medicines used to treat
The effect of desmopressin may decrease if taken at the same time as certain medicines for:
Taking desmopressin with drinks
If you are taking this medicine for enuresis or nocturia, you should limit fluid intake from 1 hour before taking a tablet until 8 hours after taking it.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Experience with the use of desmopressin during pregnancy is limited.
Desmopressin passes into breast milk, but it is unlikely to affect breastfed babies.
Driving and using machines
Desmopressin has no effects that may affect the ability to drive and use machines.
Desmopresina Aristo contains lactose(a type of sugar)
Patients with hereditary galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine.
Desmopresina Aristo contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The dose is established by your doctor, who will adjust the dose according to the response of each patient.
Desmopressin should always be taken at the same time.
The sublingual tablet should be placed under the tongue, where it dissolves without water.
Central diabetes insipidus
The recommended dose for adults and children is 1 or 2 tablets under the tongue (60 micrograms tablet) 3 times a day.
Primary nocturnal enuresis
The recommended dose is 1-2 tablets (120 micrograms) under the tongue at night. You should take this medicine at bedtime. You should limit fluid intake.
Your doctor will check every three months if you should continue treatment. Your doctor may establish a treatment-free period of at least one week.
Nocturia in adults
The recommended dose is 1 tablet (60 micrograms tablet) under the tongue at bedtime.
You should limit fluid intake.
Use in children
This medicine is used for the treatment of diabetes insipidus and nocturnal enuresis (see above for dosing for different treatments). The dose is the same for children and adults only for diabetes insipidus.
If you take more Desmopresina Aristo than you should
If you take more medicine than you should or if, for example, a child has accidentally ingested it, contact a doctor, a hospital, or a pharmacist immediately so that they can assess the risks and advise you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
An overdose can prolong the effect of desmopressin and increase the risk of fluid retention in the body and/or low sodium levels in the blood. The symptoms of severe fluid retention include convulsions and loss of consciousness.
If you forget to take Desmopresina Aristo
Do not take a double dose to make up for forgotten doses.
If you stop taking Desmopresina Aristo
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you do not limit fluid intake according to the above instructions, abnormal amounts of fluid can accumulate in the body, which can cause headaches, stomach pain, nausea/vomiting, weight gain, dizziness, confusion, discomfort, sensation of vertigo, and, in severe cases, convulsions and coma. These symptoms may lead to more or less significant fluid retention. They usually appear with high doses of desmopressin and disappear when the dose is reduced.
Adults
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(frequency cannot be estimated from the available data)
Children
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(frequency cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) via their website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Store in the original package to protect from moisture.
This medicine does not require any special storage temperature.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Desmopresina Aristo
lactose monohydrate, corn starch, citric acid (E 330), sodium croscarmellose (E 468), magnesium stearate (E 470b).
Appearance and packaging
White or almost white, octagonal, biconvex tablets, marked with the inscription "II" on one face and smooth on the other, with a diameter of 6.5 mm and a thickness of 2 mm.
Desmopressin tablets are presented in cardboard boxes containing:
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Aristo Pharma GmbH
Wallenroder Strasse 8-10
13435 Berlin,
Germany
Manufacturer
Adalvo Ltd.
Malta Life Sciences Park,
Building 1, Level 4, Sir Temi Zammit Buildings,
San Gwann, SGN 3000 Malta
Haupt Pharma Münster GmbH
Schleebruggenkamp 15,
Uppenberg
Münster
North Rhine-Westphalia
D-48159, Germany
Aristo Pharma GmbH
Wallenroder Strasse 8-10
13435 Berlin,
Germany
You can obtain further information on this medicinal product from the representative of the marketing authorisation holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medicinal product is authorised in the Member States of the European Economic Area under the following names:
Iceland Desmopressin Aristo
Austria Desmopressine Aristo
Czech Republic Desmopressin Aristo
Germany Desmopressin Aristo
Denmark Desmopressin Aristo
Italy Desmopressina Aristo
Norway Desmopressin Aristo
Portugal Desmopressina Aristo
Sweden Desmopressin Aristo
Spain Desmopresina Aristo 120 micrograms sublingual tablets EFG
Poland Desmopressin Aristo
Date of last revision of this leaflet: October 2024
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/